Divi's Laboratories Limited
DIVISLAB
주식 순위
#904
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
주가
$100.25
시가총액
$26.61B
변동 (1일)
-0.44%
변동 (1년)
33.27%
국가
IN
거래 Divi's Laboratories Limited (DIVISLAB)
카테고리
Healthcare
Divi's Laboratories Limited (DIVISLAB)의 수익
Jun 2026 기준 수익 TTM: $423.23M
Divi's Laboratories Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 $423.23M입니다. 2024년에 회사는 $259.40M의 수익을 올렸으며 이는 2023년의 수익 $288.22M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Divi's Laboratories Limited의 수익 기록 (2005 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $423.23M | 24.13% |
| 2025 | $340.95M | 31.43% |
| 2024 | $259.40M | -10.00% |
| 2023 | $288.22M | -40.60% |
| 2022 | $485.25M | 33.24% |
| 2021 | $364.19M | 50.80% |
| 2020 | $241.52M | -9.59% |
| 2019 | $267.15M | 41.26% |
| 2018 | $189.12M | -12.11% |
| 2017 | $215.17M | 2.34% |
| 2016 | $210.24M | 22.37% |
| 2015 | $171.81M | 3.93% |
| 2014 | $165.32M | 14.98% |
| 2013 | $143.78M | 7.12% |
| 2012 | $134.23M | 26.63% |
| 2011 | $106.00M | 23.55% |
| 2010 | $85.80M | -2.83% |
| 2009 | $88.29M | -6.41% |
| 2008 | $94.34M | 86.53% |
| 2007 | $50.58M | -313.15% |
| 2006 | $-23.73M | -201.27% |
| 2005 | $23.43M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 316.93% |
IN
|
